Activity of fractionated radioimmunotherapy with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC) Meeting Abstract

Ocean, A. J., Guarino, M. J., Pennington, K. L. et al. (2011). Activity of fractionated radioimmunotherapy with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC) . JOURNAL OF CLINICAL ONCOLOGY, 29(4), 10.1200/jco.2011.29.4_suppl.240



cited authors

  • Ocean, A. J.; Guarino, M. J.; Pennington, K. L.; Montero, A. J.; Bekaii-Saab, T.; Gulec, S. A.; Teoh, N.; Gold, D. V.; Wegener, W. A.; Goldenberg, D. M.

fiu authors

publication date

  • 2011

published in

Digital Object Identifier (DOI)

volume

  • 29

issue

  • 4

research area

  • Oncology  Web of Science Research Area